Milestone Pharmaceuticals Inc. (MIST) vs Rallybio Corporation (RLYB)
A side-by-side comparison of Milestone Pharmaceuticals Inc. and Rallybio Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MIST
Milestone Pharmaceuticals Inc.
$0.76HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RLYB
Rallybio Corporation
$17.08HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MIST vs RLYB
growth of $100 · dividends reinvested · last 5yMIST -85.8% (-32.3%/yr)RLYB -85.0% (-31.6%/yr)RLYB compounded faster over this window
MIST RLYB
MIST vs RLYB: by the numbers
- •MIST is the larger company ($95M vs $91M market cap).
- •RLYB is profitable (7051.24% net margin) while MIST runs a net loss (-3585.62%).
Metrics side by side
Valuation
| Metric | MIST | RLYB |
|---|---|---|
| P/E ratio | N/A | 2.19 |
| P/S ratio | 40.61 | 140.31 |
| P/B ratio | 5.22 | 0.96 |
| FCF yield | N/A | 29.06% |
Profitability
| Metric | MIST | RLYB |
|---|---|---|
| Gross margin | 94.58% | 89.28% |
| Operating margin | -4041.72% | -3270.86% |
| Net margin | -3585.62% | 7051.24% |
| ROE | -461.14% | 48.20% |
| ROIC | -49.27% | -24.40% |
Growth (annualized)
| Metric | MIST | RLYB |
|---|---|---|
| Revenue CAGR (5Y) | -31.02% | N/A |
| Total return CAGR (5Y) | -33.18% | -35.80% |
Frequently asked
- Is MIST or RLYB more profitable?
- RLYB runs the higher net margin — MIST at -3585.62% versus RLYB at 7051.24%.
- How have MIST and RLYB total returns compared?
- Over the past 5 years, MIST delivered -33.18% and RLYB delivered -35.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Rallybio P/E ratioMilestone Pharmaceuticals ROERallybio ROEMilestone Pharmaceuticals operating marginRallybio operating marginMilestone Pharmaceuticals revenue growthRallybio revenue growthMilestone Pharmaceuticals free cash flowRallybio free cash flow
Milestone Pharmaceuticals & Rallybio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.